RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy

Purpose: The lack of biomarkers that can distinguish aggressive from indolent prostate cancer has caused substantial overtreatment of clinically insignificant disease. Here, by genome-wide DNA methylome profiling, we sought to identify new biomarkers to improve the accuracy of prostate cancer diagno...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Strand, Siri H., Switnicki, Michal, Moller, Mia, Haldrup, Christa, Storebjerg, Tine M., Hedegaard, Jakob, Nordentoft, Iver, Hoyer, Soren, Borre, Michael, Pedersen, Jakob S., Wild, Peter J., Park, Jong Y., Orntoft, Torben F., Sorensen, Karina D.
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351588/
https://ncbi.nlm.nih.gov/pubmed/28052017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14391
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы